Perioperative hormone treatment of endometriosis

Abstract

Purpose of review The use of hormonally suppressive medication to reduce levels of reproductive hormones around the time of surgery is widely used in the management of endometriosis. This review summarizes the current evidence concerning the perioperative use of hormonal treatment in the management of endometriosis. Recent findings European Society of Human Reproduction and Embryology (ESHRE) guidance Surgical Outcomes and Complications of Laparoscopic Hysterectomy for Endometriosis: A Multicentre Cohort Study Pre and postsurgical medical therapy for endometriosis surgery. Cochrane 2020 Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis. BJOG 2021 Summary The literature highlights the importance of hormonal treatment for symptom relief, reduced surgical complications and postoperative benefits, including a reduction in pain, disease recurrence and improved pregnancy rates. The treatment of endometriosis can be broadly categorized into medical, commonly using hormonal suppression medications and surgical, in which endometriosis tissue is excised or ablated. This review aims to outline current management strategies and examines the relationship between the two treatment modalities.